Related Experiment Video
Updated: Jul 17, 2026

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Ischemic Postconditioning in Patients With Acute Stroke With Successful Recanalization After Endovascular Therapy: A
Yongbo Xu1, Bohao Zhang2, Shuling Liu1,3
1Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, China (Y.X., Shuling Liu, X. Jiang, Shuai Liu, K.D., X.Q., X.T., M.W.).
Stroke
|July 16, 2026
Summary
Ischemic postconditioning (IPostC) significantly reduced infarct growth in acute ischemic stroke patients after successful endovascular thrombectomy. This adjunctive therapy shows promise in limiting stroke progression, warranting further investigation in larger trials.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Interventional Radiology
Background:
- Ischemia-reperfusion injury exacerbates stroke damage even after successful recanalization.
- Ischemic postconditioning (IPostC) is a preclinical strategy to reduce infarct size.
- The clinical efficacy of IPostC as an adjunct to endovascular thrombectomy for acute ischemic stroke is not well-established.
Purpose of the Study:
- To evaluate the therapeutic effect of IPostC in reducing infarct growth in acute ischemic stroke patients.
- To determine if IPostC, applied after successful recanalization, can limit infarct expansion.
- To assess the impact of IPostC on infarct volume and clinical outcomes.
Main Methods:
- A single-center, prospective, randomized, open-label trial with blinded end point assessment was conducted.
- Patients with acute ischemic stroke undergoing successful endovascular thrombectomy were randomized to IPostC or control.
- IPostC involved cycles of balloon inflation/deflation at the occlusion site; primary outcome was infarct growth at 48-hour MRI.
Main Results:
- IPostC significantly reduced infarct growth from baseline to 48-hour MRI compared to the control group (median difference: -8.7 mL, P=0.015).
- Early infarct growth was also lower in the IPostC group (P=0.045).
- Patients receiving IPostC showed improved National Institutes of Health Stroke Scale scores at 24 hours (P=0.005), but 90-day functional outcomes did not differ significantly.
Conclusions:
- IPostC performed after successful recanalization is a promising adjunctive therapy for reducing infarct growth in acute ischemic stroke.
- These pilot findings suggest IPostC may limit stroke progression and improve early neurological deficits.
- Larger randomized trials are necessary to confirm these results and establish the role of IPostC in stroke management.
